Floreani A, Niro G, Rosa Rizzotto E, Antoniazzi S, Ferrara F, Carderi I, Baldo V, Premoli A, Olivero F, Morello E, Durazzo M
Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy.
Aliment Pharmacol Ther. 2006 Oct 1;24(7):1051-7. doi: 10.1111/j.1365-2036.2006.03104.x.
Many reports of autoimmune hepatitis (AIH) were written in the 'pre-Hepatitis C era' and data on the natural history are still incomplete.
To evaluate the clinical presentation and the natural history of type I AIH.
Seventy-three consecutive patients with a regular follow-up of at least 2 years were prospectively included in the study. The mean follow-up was 91 +/- 61 months.
Patients with 'acute' onset at presentation were significantly older than patients with 'chronic' onset (P < 0.05) and had significantly higher serum levels of transaminase, gamma-glutamyltransferase and bilirubin; Prothrombin time was significantly lower in the said group compared with AIH patients with 'chronic' onset. In 4 of 63 (6.3%) female patients, AIH had the onset during pregnancy; in all of them the outcome of pregnancy was favourable. The major events during the follow-up included oesophageal varices (n = 9) and ascites (n = 4), and 60 patients remained in remission while receiving immunosuppression. None of the patients died during the follow-up, but seven patients were transplanted. The cumulative transplant-free probability of survival was 73.5% at 280 months.
Elderly patients have more frequently an acute onset at presentation. Survival in AIH is apparently good; with early diagnosis, and improved medical therapy, liver transplantation for AIH will become a rare event in future.
许多自身免疫性肝炎(AIH)的报告是在“丙型肝炎时代之前”撰写的,关于其自然史的数据仍然不完整。
评估Ⅰ型AIH的临床表现和自然史。
前瞻性纳入73例连续接受至少2年定期随访的患者。平均随访时间为91±61个月。
呈现“急性”起病的患者比“慢性”起病的患者年龄显著更大(P<0.05),血清转氨酶、γ-谷氨酰转移酶和胆红素水平显著更高;与“慢性”起病的AIH患者相比,该组患者的凝血酶原时间显著更低。在63例女性患者中有4例(6.3%)在妊娠期间发生AIH;她们所有妊娠结局均良好。随访期间的主要事件包括食管静脉曲张(n = 9)和腹水(n = 4),60例患者在接受免疫抑制治疗时仍处于缓解状态。随访期间无患者死亡,但有7例患者接受了肝移植。280个月时无移植生存的累积概率为73.5%。
老年患者呈现急性起病的情况更为常见。AIH患者的生存率显然良好;随着早期诊断和医疗治疗的改善,未来AIH患者进行肝移植将成为罕见事件。